Breast Cancer Trial

Triple-Negative, Including Men

Platinum-Based Chemotherapy or Capecitabine in Treating Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy

Update on March 30, 2021: Study EA1131 is now closed to patient enrollment.

National Cancer Institute: Trial record on cancer.gov

ClinicalTrials.gov Record/ID: NCT02445391

Return to Home Page | Review Other Active Trials